Article info
Multiple sclerosis
Research paper
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
- Correspondence to A/Prof Tomas Kalincik, CORe, Department of Medicine, University of Melbourne, Melbourne, VIC 3050, Australia; tomas.kalincik{at}unimelb.edu.au
Citation
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
Publication history
- Received October 15, 2018
- Revised December 7, 2018
- Accepted December 14, 2018
- First published January 13, 2019.
Online issue publication
April 09, 2019
Article Versions
- Previous version (13 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.